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CDC Accepts ACIP Recommendations Regarding Smallpox Vaccination 
and Cardiac Events and Distributes Revised Pre-Vaccination Education 
Materials
The ACIP held an emergency meeting by conference call on Friday, March 28, 2003, to make recommendations 
to CDC regarding cases o f cardiac adverse events that have been reported follow ing sm allpox vaccination, 
including myocarditis and/or pericarditis, myocardial infarction, and angina.
The available data suggest that sm allpox vaccine can cause myocarditis and/or pericarditis. However, the number 
o f cases o f angina and myocardial infarction reported are compatible with the expected background rate. This 
means that observed angina and heart attack cases may have a coincidental rather than a causal relation to the 
vaccine. Nevertheless, as a precautionary measure, it is prudent to defer vaccination at this time o f persons most 
at risk fo r heart attacks and angina, independent o f vaccination.
Therefore, the ACIP recommended that persons be excluded from the pre-event sm allpox vaccination program 
who have been diagnosed as having a heart condition or ischemic cardiovascular condition, with or w ithout 
symptoms (such as previous myocardial infarction, angina, congestive heart failure, cardiomyopathy, stroke or 
transient ischemic attack, or other heart conditions under the care o f a doctor). The Committee also 
recommended that persons be excluded if they have three or more known m ajor cardiac risk factors including 
hypertension, diabetes, hypercholesterolem ia, and smoking. A fter consulting with experts in cardiology, CDC 
added to th is the additional risk factor o f having an immediate fam ily m em ber who has had onset o f a heart 
condition before age 50. The Committee supported including the risk factors in pre-vaccination clinic education 
materials, so potential vaccinees could evaluate their risk status with the ir personal physician prior to presentation 
fo r vaccination if they had concerns; at the vaccination clinic, verbal screening fo r known risk factors was 
recommended.
The Committee did not recommend special medical follow-up fo r persons with cardiovascular risk factors who had 
been vaccinated. Persons with risk factors or known atherosclerotic coronary artery disease should be cared for 
by their physicians in accordance with standard guidelines fo r treatm ent and control o f these conditions.
CDC has accepted the ACIP recommendations and has revised and distributed fact sheets and pre-vaccination 
clinic education and screening materials that reflect the new exclusion criteria. These revised forms, dated March 
31 2003, replace previously distributed versions and should be used immediately in sm allpox vaccination clinics. 
The materials are available at www.cdc.gov/smallpox.
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There is evidence suggesting that sm allpox vaccination may cause cases o f heart inflammation (myocarditis), 
inflammation o f the membrane covering the heart (pericarditis), and a combination o f these two problems 
(myopericarditis). Most reported cases have occurred in m ilitary personnel, who received more than 350,000 
doses o f sm allpox vaccine since December 13, 2002. Overall, m ilitary personnel experienced a rate of 
myopericarditis o f approximately 1 per 20,000 primary vaccinated persons (i.e., people vaccinated fo r the first 
time). This rate is much higher than expected based on historical data and experience. There have been no cases 
in m ilitary people who had previously received the sm allpox vaccine. Cases, aged 21 to 33 years, ranged from 
mild (no ECG or echocardiogram changes) to severe (transient heart failure), with onset 7 to 19 days after 
vaccination. They all survived. The newest case is still in the hospital as o f March 31, 2003. The others have been 
discharged from hospital, and have either returned to duty or are on short-term  convalescent leave to regain their 
strength.
In the civilian sm allpox vaccination program, as o f March 21, 2003, 25,645 persons had been vaccinated. One 
case of myocarditis and 2 cases o f pericarditis have been reported to date. Patients were 45, 45, and 56 years of 
age, and two were reported to be revaccinees; the vaccination status o f the other patient is unknown. Dates of 
onset were 2 days, 12 days, and 17 days following vaccination; the patient with onset at 2 days had some 
symptoms prior to vaccination.
As o f March 30, 2003, s ix  ischemic (e.g., heart attacks or angina) events - 4 heart attacks and 2 cases o f angina - 
have been reported among civilian vaccinees within 3 weeks o f vaccination. Two o f the heart attacks presented 
as out-of-hospital cardiac arrests, and both patients died. Patients ranged in age from  43 to 69 years; all but one 
were 54 years o f age or older. All but one patient had known cardiac risk factors; four are known to have three or 
more risk factors, and thus would have been excluded from vaccination by the ACIP 's new recommendations for 
pre-vaccination screening (we are still awaiting clinical information on the most recently reported case, and it is 
possible that that case would have been excluded as well). Additionally, a 55 year old m ilitary vaccinee died 
following vaccination. Autopsy showed a prior myocardial infarction, three-vessel coronary artery disease, and left 
ventricular hypertrophy. H istopathology revealed evidence of no m yo-pericarditis in this man.
The Centers fo r  Disease C ontro l and Prevention (CDC) p ro tec ts  people 's hea lth  and  sa fe ty  by p reven ting  and  
contro lling  diseases and  in ju rie s ; enhances hea lth  decisions by p rov id ing  credib le in fo rm a tion  on c ritica l health  
issues; and  prom otes hea lthy liv in g  th rough s trong  partnersh ips w ith  loca l, na tiona l and  in te rna tiona l
organizations.
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